Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Advancements in Soft Tissue Sarcoma Research and Treatment

Paul Colon*

Soft tissue sarcoma (STS) is a rare and diverse group of malignancies originating from soft tissues, presenting significant challenges in diagnosis and treatment. However, recent advancements in STS research and treatment have brought new hope to patients and healthcare professionals alike. This abstract highlights some of the key breakthroughs in STS research and treatment strategies. Genomic profiling has emerged as a critical tool, providing insights into the genetic alterations and molecular pathways driving STS development. By identifying specific gene mutations unique to various subtypes, personalized treatment approaches, including targeted therapies and immunotherapies, have been developed to exploit tumor vulnerabilities effectively.